EUCTR2004-005187-24-IT进行中（未招募）不适用
Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subjects with chronic non-malignant pain severe enough to require continuous opioid therapy.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subjects with chronic non-malignant pain severe enough to require continuous opioid therapy - OROS hydromorphone once daily vs. Oxycodone twice daily in subjects with chronic non-malignant paiEUCTR2004-005187-24-DEJanssen Cilag Medical Affairs EMEA504
进行中（未招募）
不适用
Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subjects with chronic non-malignant pain requiring continuous opioid therapyChronic non-malignant painEUCTR2004-005187-24-CZJanssen-Cilag Medical Affaires EMEA
进行中（未招募）
1 期
Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subjects with chronic non-malignant pain requiring continuous opioid therapyEUCTR2004-005187-24-SKJanssen-Cilag Medical Affaires EMEA504
尚未招募
3 期
se of HYDRODENG SACHET in Dengue fever patientsCTRI/2024/04/065599Tirupati Medicare Limited, India.
已完成
4 期
The comparative study of Nadifloxacin and Mupirocin in children with skin and soft tissue infectioCTRI/2018/03/012411Dr Swapnil Janbandhu60